Drugs / S-740792
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06724978 | Nov 2024 → Sep 2025 | — | Shionogi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S-740792 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06724978 ↗ |
| Route | Oral | “Participants will receive S-740792 as an oral suspension.” NCT06724978 ↗ |